PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
9890792-2	1975	Slight inhibition (5 to 20%) of GABA-T activity was seen with chlordiazepoxide (0.1 mM), ethosuximide (0.1 mM) and di-n-propylacetate (0.1 mM).	di-n-propylacetate	115-133	4-aminobutyrate aminotransferase	Mus musculus	32-38
991920-3	1976	The ED50 for picrotoxin convulsions was significantly raised by di-n-propylacetate (800 mg/kg) which inhibited GABA transaminase activity by 6% and elevated brain GABA concentration by 26%.	di-n-propylacetate	64-82	4-aminobutyrate aminotransferase	Homo sapiens	111-128
781711-1	1976	Di-n-propylacetate (DPA), a drug known to increase brain gamma-aminobutyric acid (GABA) levels and to inhibit GABA-transamine (GABA-T) activity, was administered during the ethanol withdrawal period to rats made physically dependent upon ethanol.	di-n-propylacetate	0-18	4-aminobutyrate aminotransferase	Rattus norvegicus	110-125
781711-1	1976	Di-n-propylacetate (DPA), a drug known to increase brain gamma-aminobutyric acid (GABA) levels and to inhibit GABA-transamine (GABA-T) activity, was administered during the ethanol withdrawal period to rats made physically dependent upon ethanol.	di-n-propylacetate	0-18	4-aminobutyrate aminotransferase	Rattus norvegicus	127-133